Stock Events

BioPharma Credit 

GBX67.43
46
+GBX0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
7.84%
Dividend
5.29

Upcoming

31
JUL
Dividend Payment
25
SEP
Earnings
7
DEC
Dividend Ex
5
JAN 25
Dividend Payment
15
FEB 25
Dividend Ex
15
MAR 25
Dividend Payment
28
MAR 25
Dividend Ex
30
APR 25
Dividend Payment
4
JUL 25
Dividend Ex
31
JUL 25
Dividend Payment

Dividends

7.84%Dividend Yield
Jul 24
GBX1.32
Apr 24
GBX1.37
Mar 24
GBX1.36
Mar 24
GBX0.94
Jan 24
GBX1.39
10Y Growth
N/A
5Y Growth
-0.11%
3Y Growth
2.17%
1Y Growth
-2.22%

Earnings

25SepExpected
Q4 2021
Q2 2022
Q4 2022
Q2 2023
Q4 2023
Q1 2024
Next
0.03
0.04
0.04
0.05
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BPCP.LSE. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BridgeBio Pharma
BBIO
Mkt Cap4.9B
BridgeBio Pharma focuses on genetic diseases and competes in the biopharma financing space by attracting investments for its projects.
Pfizer
PFE
Mkt Cap169.83B
Pfizer is a large pharmaceutical company with a significant investment arm for biopharma ventures, competing for similar investment opportunities.
Gilead Sciences
GILD
Mkt Cap90.4B
Gilead Sciences invests in biopharma companies and projects, directly competing with BioPharma Credit's investment model.
Bristol-Myers Squibb
BMY
Mkt Cap86.44B
Bristol Myers Squibb, through its venture arm, competes in the biopharma credit and investment space.
Merck &
MRK
Mkt Cap318.55B
Merck & Co., with its venture capital initiatives, competes for similar biopharma investments and financing opportunities.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson, through its J&J Innovation and JLABS units, competes in the biopharma investment and financing space.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie, with its venture investment arm, competes for opportunities in biopharma credit and financing.
AMGEN
AMGN
Mkt Cap177.72B
Amgen, through its venture investments, competes in the biopharma financing space, targeting similar companies and projects.
Novartis
NVS
Mkt Cap232.42B
Novartis, with its significant investments in biopharma companies, competes directly with BioPharma Credit's financing model.
Sanofi
SNY
Mkt Cap128.21B
Sanofi, through its venture capital arm, competes in the biopharma credit market, financing similar types of companies and projects.

About

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
Show more...
CEO
Country
GB
ISIN
GB00BDGKMY29
WKN
000A2DN3S

Listings

F
DE
B3P.F
LSE
GB
BPCP.LSE
LSE
GB
BPCR.LSE
OTCM
US
BOPCF